Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

作者：Youyi Fong, Adrian B. McDermott, David C. Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch, Mathieu Le Gars, Griet A. Van Roey, Christopher R. Houchens, Karen A. O. Martins, Lakshmi Jayashankar, Flora Castellino, Obrimpong Amoa-Awua, Manjula Basappa, Britta Flach, Bob C. Lin, Christopher A. Moore, Mursal Naisan, Muhammed Naqvi, Sandeep Narpala, Sarah E. O’Connell, Allen Mueller, Leo Serebryannyy, Mike Castro, Jennifer P Wang, Christos J. Petropoulos, Alex R. Luedtke, Ollivier Hyrien, Yiwen Lu, Chenchen Yu, Bhavesh R. Borate, Lars W. P. van der Laan, Nima S. Hejazi, Avi Kenny, Marco Carone, Daniel Wolfe, JERALD C. SADOFF, Glenda Gray, Beatriz Gilda Jegerhorn Grinsztejn, Paul Goepfert, Susan J. Little, Leonardo Paiva de Sousa, Rebone Maboa, April Kaur Randhawa, Michele Peake Andrasik, Jenny Hendriks, Carla Truyers, Frank Struyf, Hanneke Schuitemaker, Macaya Douoguih, James G. Kublin, Lawrence Corey, Kathleen Maletic Neuzil, Lindsay N. Carpp, Dean A. Follmann, Peter B. Gilbert, Richard A. Koup, Rubén O. Donis, on behalf of the Immune Assays Team, the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team, and the United States Government (USG)/CoVPN Biostatistics Team · 发表于：Nature Microbiology · 年份：2022 · DOI：10.1038/s41564-022-01262-1 · 被引用次数：95 · 研究领域：SARS-CoV-2 and COVID-19 Research、Biosimilars and Bioanalytical Methods、CAR-T cell therapy research